Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

silica/bólga

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 17 niðurstöður

Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD The present invention relates to a depot for drug delivery. In particular the present invention relates to a depot suitable for sustained-release drug delivery. Further the present invention relates to use of a depot in the preparation of a parenteral sustained-release medicament. In

Nanoparticle-stabilized capsule formulation for treatment of inflammation

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to a formulation for the delivery of an anti-inflammatory agent to a subject. In a particular application of the invention, the formulation comprises oil-based or aqueous droplets comprising indomethacin

Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The invention concerns new substances based upon fine pyrogenic silica, or AEROSIL (commercial pharmaceutical names SILARD P, SILEX, ATOXIL) that contains serrathiopeptidase immobilized thereon. Such composition is active in the lysis of necrotizing tissues, cleanses wound

Anti-inflammatory activity of a specific turmeric extract

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH This invention was made with government support under Grant No. P50 AT00474 awarded by the National Institute of Health. The United States Government has certain rights in this invention. TECHNICAL FIELD The present invention is relevant to the field
CROSS-REFERENCE TO RELATED APPLICATIONS None. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT None. REFERENCE TO SEQUENCE LISTING None. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component is identified as quinic acid lactone. The present
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid

Nanoparticle-mediated delivery of cytokines for maintenance of the regulatory T cell phenotype

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention is generally in the field of delivery of the combination of IL-2 and TGF-.beta., using nanoparticulates, which may be targeted to CD4 expressed by a desired cell or tissue type to enhance efficacy BACKGROUND OF THE INVENTION CD4+ T cells represent an

Nanoparticle-mediated delivery of cytokines for maintenance of the regulatory T cell phenotype

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention is generally in the field of delivery of the combination of IL-2 and TGF-.beta., using nanoparticulates, which may be targeted to CD4 expressed by a desired cell or tissue type to enhance efficacy. BACKGROUND OF THE INVENTION CD4+ T cells represent an

Method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the chemistry of biologically active compounds. More particularly to specifically substituted porphyrin and chlorin derivatives that can be used as photosensitizers for a wide range of light irradiation treatments such as

Specifically meso-substituted porphyrins and chlorins for photodynamic therapy

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the chemistry of biologically active compounds. More particularly to specifically substituted porphyrin and chlorin derivatives that can be used as photosensitizers for a wide range of light irradiation treatments such as

Oral dentrifice power and method

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD The invention relates to oral hygiene, including cleaning of the teeth and gums, and supplemental addition of trace elements and calcium to the teeth and gums. BACKGROUND Tooth powder as used in daily life, has a long history. With the continuous development of science and
FIELD OF THE INVENTION This invention belongs to pharmaceutical preparations suitable for preparing solutions for injectable preparations of antimicrobial pharmaceuticals, and to technologies for compounding thereof; it may be used in medicine and veterinary medicine when treating contagious and

Coated intraocular lens

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION The present invention relates to an ophthalmic prosthetic device and more particularly to an anti-reactive coated intraocular lens. As is well known in the field of ophthalmology, an intraocular lens, when surgically implanted, is designed to replace a previously or
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge